[HTML] nih.gov

[HTML][HTML] Efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer

Y Zhong, Q Wei, Y Lu, X Tang, Z Wang… - Journal of thoracic …, 2020 - ncbi.nlm.nih.gov
Background Non-small cell lung cancer (NSCLC) is the most common type of lung cancer
and its incidence seriously affects human health. The purpose of this study was to evaluate …
被引用次数：10 相关文章
[PDF] amegroups.cn

[PDF][PDF] Efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer

Y Zhong, Q Wei, Y Lu, X Tang, Z Wang… - Journal of Thoracic …, 2020 - cdn.amegroups.cn
Background: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer
and its incidence seriously affects human health. The purpose of this study was to evaluate …
[HTML] amegroups.org

[HTML][HTML] Efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer

Y Zhong, Q Wei, Y Lu, X Tang, Z Wang… - Journal of Thoracic …, 2020 - jtd.amegroups.org
Background: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer
and its incidence seriously affects human health. The purpose of this study was to evaluate …

Efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer

Y Zhong, Q Wei, Y Lu, X Tang… - Journal of thoracic …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Non-small cell lung cancer (NSCLC) is the most common type of lung cancer
and its incidence seriously affects human health. The purpose of this study was to evaluate …

Efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer.

Y Zhong, Q Wei, Y Lu, X Tang, Z Wang… - Journal of Thoracic …, 2020 - europepmc.org
Background Non-small cell lung cancer (NSCLC) is the most common type of lung cancer
and its incidence seriously affects human health. The purpose of this study was to evaluate …

Efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer

Y Zhong, Q Wei, Y Lu, X Tang, Z Wang… - Journal of Thoracic …, 2020 - jtd.amegroups.org
Efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer - Zhong
- Journal of Thoracic Disease Have a website account?Log In orRegister for exclusive …